The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Neurocrine Biosciences, Inc. shares valued at $1,050,590 were sold by Lippoldt Darin on Jul 16 ’24. At $150.00 per share, Lippoldt Darin sold 7,004 shares. The insider’s holdings dropped to 39,740 shares worth approximately $5.8 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Delaet Ingrid sold 2,857 shares, netting a total of over 428,627 in proceeds. Following the sale of shares at $150.03 each, the insider now holds 6,607 shares.
Before that, LYONS GARY A had sold 930 shares from its account. In a trade valued at $139,530, the Director traded Neurocrine Biosciences, Inc. shares for $150.03 each. Upon closing the transaction, the insider’s holdings decreased to 930 shares, worth approximately $17.37 million.
As published in a research note from Wells Fargo on April 24, 2024, Neurocrine Biosciences, Inc. [NBIX] has been rated up from an Equal weight to an Overweight and the price target has been revised to $170 from $140. As of December 12, 2023, Deutsche Bank has initiated its “Buy” rating for NBIX.
Analyzing NBIX Stock Performance
During the last five days, there has been a surge of approximately 0.85%. Over the course of the year, Neurocrine Biosciences, Inc. shares have jumped approximately 10.72%. Shares of the company reached a 52-week high of $150.39 on 07/16/24 and a 52-week low of $128.00 on 02/07/24. A 50-day SMA is recorded $139.15, while a 200-day SMA reached $131.11. Nevertheless, trading volume fell to 0.62 million shares from 0.43 million shares the previous day.
Support And Resistance Levels for Neurocrine Biosciences, Inc. (NBIX)
According to the 24-hour chart, there is a support level at 144.29, which, if violated, would cause prices to drop to 142.69. In the upper region, resistance lies at 147.16. The next price resistance is at 148.43. RSI (Relative Strength Index) is 60.97 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.42, which suggests the price will decrease in the coming days. Percent R is at 31.02%, indicating low price movement. Stochastics%K at holding indicates that the stock is to be held.
